SYRE vs CORT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

SYRE

66.4
AI Score
VS
SYRE Wins

CORT

58.0
AI Score

Investment Advisor Scores

SYRE

66score
Recommendation
BUY

CORT

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SYRE CORT Winner
Net Income -151.72M 11.23M CORT
Operating Income -147.31M -8.30M CORT
ROE -46.3% 1.6% CORT
ROA -36.0% 1.3% CORT
Total Assets 421.09M 888.70M CORT
Cash 71.58M 111.04M CORT
Current Ratio 7.32 2.86 SYRE

Relative Price Performance (Last 90 Days)

SYRE 1M: -13.0% · 3M: +12.2% CORT 1M: +0.5% · 3M: +35.5%

Current Technical Phase

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $90.60

CORT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.4% over 20 days), RSI 51

RSI (14): 50.8 · Price: $112.79

Fundamentals Snapshot

Metric SYRE CORT
Market Cap
Forward P/E -25.7 25.6
Trailing P/E 255.4
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin 1.0%
Operating Margin 0.0% 0.2%
EPS -1.96 0.45
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.